Disruption of medial prefrontal synchrony in the subchronic phencyclidine model of schizophrenia in rats

5Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

Abstract

Subchronic treatment with the N-methyl-. d-aspartate (NMDA) antagonist phencyclidine (PCP) produces behavioral abnormalities in rodents which are considered a reliable pharmacological model of neurocognitive deficits in schizophrenia. Alterations in prefrontal neuronal firing after acute PCP administration have been observed, however enduring changes in prefrontal activity after subchronic PCP treatment have not been studied. To address this we have recorded cortical oscillations and unit responses in putative cortical pyramidal cells in subchronic PCP-treated rats (2. mg/kg twice daily for 7. days) under urethane anesthesia. We found that this regimen reduced theta oscillations in the medial prefrontal cortex. It further produced abnormal cortical synchronization in putative cortical pyramidal cells. These alterations in prefrontal cortex functioning may contribute to cognitive deficits seen in subchronic NMDA antagonist pre-treated animals in prefrontal-dependent tasks.

Cite

CITATION STYLE

APA

Young, A. M. J., Stubbendorff, C., Valencia, M., & Gerdjikov, T. V. (2015). Disruption of medial prefrontal synchrony in the subchronic phencyclidine model of schizophrenia in rats. Neuroscience, 287, 157–163. https://doi.org/10.1016/j.neuroscience.2014.12.014

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free